InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Controversial cancer patent upheld by EPO

James Nurton, London


An EPO Technical Board of Appeal has maintained a controversial patent for diagnosing a predisposition for breast and ovarian cancer in amended form

The patent, number 699,754, was filed by Myriad Genetics, the University of Utah Research Foundation and the USA. It was published in 1996.

As approved by the Board, it covers diagnostic methods for detecting a predisposition...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Latest Country Updates

Supplements

Most read articles